Strategic Workshops Supporting Pharma’s Future

How to deliver the degree of holistic and objective understanding that today’s market demands

For any company seeking success, strategic intelligence is crucial.

For the pharma industry, the questions surrounding how to win have become increasingly complex, and the answers even more so. Distilling and prioritising the information crucial to strategy-formation can appear a labrynthine task.

So how do you deliver the degree of holistic – and objective – understanding that today’s circuitous market demands? Should you challenge your existing business model? And how can you prepare for the next disruption?

Breakthrough thinking, we’ve seen, lies in the prioritization of a full Strategic Preparedness Workshop (SPW). The SPW goes far beyond traditional pharma workshops that assess one or a few competitors or helps to clarify the path to an already clear-cut goal. Instead, SPWs align key stakeholders early in the direction setting process via a thorough exploration of the strategic challenges, disruptors, and opportunities facing a company. SPWs give leaders a chance to align, engage, and explore the best strategic approach based on deep knowledge of external as well as internal success factors.

In this paper, we’ll show how SPWs should be run – and why.

DOWNLOAD WHITE PAPER

You may also be interested in…

  • HIV & AIDS Medication

HIV/AIDS

Human immunodeficiency virus (HIV) is the virus that is responsible for Acquired Immune Deficiency Syndrome (AIDS). HIV continues to be a major global public health issue having claimed the lives of 36.3 million people so far, according to World Health Organization (WHO).

  • Post-ASCO 2022- Summary of key breast cancer highlights

Post-ASCO 2022: Summary of key breast cancer highlights

With the conclusion of another ASCO, we were presented with exciting new breakthrough data of Antibody Drug Conjugates in breast cancer. Enhertu (trastuzumab deruxtecan) demonstrated significant benefit in the treatment of a new subtype of breast cancer, HR+/ /HER2-low.

BIO 2022: Biotechnology Innovation Organization (BIO) Convention

We’re excited to be attending The BIO International Convention. Jack Florio, Partner in Strategy Consulting at Deallus will be joining more than 3,000 delegates and exploring the latest innovation within the biotech space, as well as making the most of opportunities to meet and network with global thought leaders and industry peers.